CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Revenue | $ 6,136 | $ 5,511 | $ 12,398 | $ 8,879 |
| Cost of revenue | 3,947 | 8,231 | 8,268 | 11,289 |
| Gross profit | 2,189 | (2,720) | 4,130 | (2,410) |
| Research and development expenses | 24,889 | 22,841 | 47,715 | 44,410 |
| General and administrative expenses | 10,216 | 7,969 | 22,568 | 15,186 |
| Selling and marketing expenses | 1,644 | 1,393 | 3,543 | 3,335 |
| Total operating expenses | 36,749 | 32,203 | 73,826 | 62,931 |
| Operating loss | (34,560) | (34,923) | (69,696) | (65,341) |
| Interest income | 893 | 619 | 1,770 | 1,626 |
| Change in fair value of warrant liabilities | (44,700) | (88,478) | (44,250) | (93,878) |
| Fair value loss on share subscription liability | 0 | (69,996) | 0 | (69,996) |
| Interest expense | (1,196) | 0 | (2,379) | 0 |
| Other income (expense), net | (3) | 106 | 42 | 107 |
| Loss before income taxes | (79,566) | (192,672) | (114,513) | (227,482) |
| Income tax provision | 58 | 70 | 90 | 127 |
| Net income | (79,624) | (192,742) | (114,603) | (227,609) |
| Unrealized loss on available-for-sale securities, net of tax | (58) | 2 | (84) | (52) |
| Total comprehensive loss | $ (79,682) | $ (192,740) | $ (114,687) | $ (227,661) |
| Net loss per share, Basic | $ (1.23) | $ (3.49) | $ (1.8) | $ (4.14) |
| Net loss per share, Diluted | $ (1.23) | $ (3.49) | $ (1.8) | $ (4.14) |
| Weighted-average shares used in computing net income (loss) per share - Basic | 64,672,666 | 55,161,124 | 63,745,534 | 54,956,722 |
| Weighted-average shares used in computing net income (loss) per share - Diluted | 64,672,666 | 55,161,124 | 63,745,534 | 54,956,722 |
| Product | ||||
| Revenue | $ 2,546 | $ 4,203 | $ 4,973 | $ 6,684 |
| Cost of revenue | 2,614 | 3,992 | 5,651 | 6,575 |
| Professional service | ||||
| Revenue | 3,590 | 1,308 | 7,425 | 2,195 |
| Cost of revenue | $ 1,333 | $ 4,239 | $ 2,617 | $ 4,714 |
| X | ||||||||||
- Definition Fair value loss on share subscription liability No definition available.
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|